Written By:
Dr. D Prabhakar
Dr. D Prabhakar
Published On: 17 Aug, 2022 3:57 PM
Apolipoprotein B
- Measurement of LDL-C and HDL-C are inaccurate, so why measure?
- All the apoB-containing particles are atherogenic; the measurement of apoB encompasses all of them, which must be reduced.
- On treatment, apoB reduction is a better marker. The discordance is more since LDL-C-lowering is more than apoB.
- Both in primary and secondary prevention cohorts – ApoB is better predictor.
- Clear targets, no fasting sample required. Cost is reasonable.
Related FAQs
Familial Hypercholesterolemia
Coronary Calcium Screening and Role in Preventive Cardiology
Non-HDL Cholesterol
Diagnosis of Familial Hypercholesterolemia
Lipid and Lab Reporting
LAI Recommendations for the Use of Bempedoic Acid
Current and Future Treatment of Severe Hypercholesterolemia
Pillars of Heart Failure Management: Implementation and Outcomes with an Emphasis on SGLT2 Inhibitor and Beta-blockers
Dyslipidemia in Hypertension: Importance of Statins for Primary Prevention
ASCVD Risk Reduction in Persons with Hypertriglyceridemia: Role of Icosapent Ethyl
